share_log

CareMax Analyst Ratings

CareMax Analyst Ratings

CareMax 分析師評級
Benzinga ·  2023/11/17 17:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/17/2023 6.3% UBS $5 → $1 Downgrades Buy → Neutral
11/10/2023 112.61% Piper Sandler → $2 Downgrades Overweight → Neutral
01/06/2023 537.82% UBS $10 → $6 Maintains Buy
09/07/2022 697.28% Truist Securities → $7.5 Initiates Coverage On → Hold
10/20/2021 1494.56% Jefferies → $15 Initiates Coverage On → Buy
09/13/2021 Piper Sandler Upgrades Neutral → Overweight
09/10/2021 1388.25% Cowen & Co. → $14 Initiates Coverage On → Outperform
07/01/2021 1388.25% Piper Sandler → $14 Initiates Coverage On → Neutral
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
11/17/2023 6.3% 瑞銀(UBS) 5 美元 → 1 美元 降級 買入 → 中性
11/10/2023 112.61% 派珀·桑德勒 → 2 美元 降級 超重 → 中性
01/06/2023 537.82% 瑞銀(UBS) 10 美元 → 6 美元 維護
09/07/2022 697.28% Truist 證券 → 7.5 美元 啓動覆蓋範圍開啓 → 按住
2021 年 10 月 20 日 1494.56% 傑富瑞集團 → 15 美元 啓動覆蓋範圍開啓 → 購買
09/13/2021 派珀·桑德勒 升級 中性 → 超重
2021 年 10 月 9 日 1388.25% Cowen & Co. → 14 美元 啓動覆蓋範圍開啓 → 跑贏大盤
07/01/2021 1388.25% 派珀·桑德勒 → 14 美元 啓動覆蓋範圍開啓 → 中立

What is the target price for CareMax (CMAX)?

CareMax(CMAX)的目標價格是多少?

The latest price target for CareMax (NASDAQ: CMAX) was reported by UBS on November 17, 2023. The analyst firm set a price target for $1.00 expecting CMAX to rise to within 12 months (a possible 6.30% upside). 3 analyst firms have reported ratings in the last year.

瑞銀於2023年11月17日公佈了CareMax(納斯達克股票代碼:CMAX)的最新目標股價。該分析公司將目標股價定爲1.00美元,預計CMAX將在12個月內升至12個月內(可能上漲6.30%)。去年有3家分析公司公佈了評級。

What is the most recent analyst rating for CareMax (CMAX)?

分析師對CareMax(CMAX)的最新評級是多少?

The latest analyst rating for CareMax (NASDAQ: CMAX) was provided by UBS, and CareMax downgraded their neutral rating.

瑞銀對CareMax(納斯達克股票代碼:CMAX)的最新分析師評級由瑞銀提供,CareMax下調了中性評級。

When is the next analyst rating going to be posted or updated for CareMax (CMAX)?

CareMax(CMAX)的下一次分析師評級將在何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareMax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareMax was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表、與CareMax的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。CareMax的最新評級是在2023年11月17日公佈的,因此您應該預計下一個評級將在2024年11月17日左右公佈。

Is the Analyst Rating CareMax (CMAX) correct?

分析師對CareMax(CMAX)的評級是否正確?

While ratings are subjective and will change, the latest CareMax (CMAX) rating was a downgraded with a price target of $5.00 to $1.00. The current price CareMax (CMAX) is trading at is $0.94, which is out of the analyst's predicted range.

儘管評級是主觀的,並且會發生變化,但最新的CareMax(CMAX)評級已下調,目標股價爲5.00美元至1.00美元。CareMax(CMAX)目前的交易價格爲0.94美元,超出了分析師的預期區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論